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White blood cell differentials in dogs with congestive heart failure (CHF) in comparison to those in 
dogs without cardiac disease.  
Objectives: To determine if dogs with congestive heart failure have different white blood cell 
differentials in comparison to dogs without cardiac disease. 
Methods: 72 canine CHF patients (mitral valve disease or dilated cardiomyopathy; cases) and 143 
dogs without cardiac disease (controls) were retrospectively recruited. Signalment, white blood cell 
differentials and echocardiography data were retrieved. Basic statistical analysis was performed on 
white blood cell differentials. Principal components analysis was performed to compare white blood 
cell differentials in cases and controls with age, sex and case/control status as supplementary 
variables. Cases and controls were compared with binary logistic regression for the principal 
components identified and individual WBC differentials. Principal components analysis of cases alone 
was conducted with age, sex, weight, mitral E wave:isovolumic relaxation time as supplementary 
variables. Linear regression analysis was used to explore the association between mitral E 
wave:isovolumic relaxation time and the principal components, weight, sex, age and diagnosis 
(mitral valve disease or dilated cardiomyopathy). 
Results:  Amongst cases and controls, the largest variance in data (component 1) associated with 
neutrophils, band neutrophils, monocytes and case status (p<0.01). The odds of an individual being a 
case increased 2.5 (95% confidence interval: 1.4-4.4) fold for each unit increase in component 1. 
Amongst the cases, mitral E wave:isovolumic relaxation time associated with neutrophil count and 
diagnosis.. 
Conclusion: Dogs with CHF have statistically significant increases in neutrophils, band neutrophils and 
monocytes in comparison to those without cardiac disease however these changes remain within 
normal reference ranges.  
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Introduction 
Congestive heart failure (CHF) is a common pathological syndrome in canine patients and a frequent 
consequence of advanced structural or functional cardiac disease, including myxomatous mitral 
valve disease (MVD) and dilated cardiomyopathy (DCM) (Bonnett et al. 2005). However, the 
underlying pathophysiology is incompletely understood. Cardiac remodelling leading to CHF is a 
complex process involving alterations in gene expression and molecular, cellular and interstitial 
changes influenced by haemodynamic loading, neurohormonal activation and activation of the 
immune system (Cohn at al. 2000).  
In humans, it is well established that immune activation is an important component of CHF and 
inflammatory mediators including pro-inflammatory cytokines (e.g. interleukin 1ß, interleukin 6, C-
reactive protein (CRP) and nitric oxide contribute to progression and prognosis in both acute and 
chronic disease (Deswal et al. 2001; Anker and Von Haehling 2004; Eisen et al. 2014; Li et al. 2014).  
More recently, activation of the immune system has been documented in canine CHF.  Several 
studies have reported increased levels of acute phase proteins (e.g. CRP and haptoglobin), pro-
inflammatory cytokines (e.g. pro-inflammatory interleukin-1β) and anti-fibrotic matrix 
metalloproteinase 1 in canine MVD patients with CHF (Rush et al.2006, Cunningham et al. 2012; 
Fonfara et. al 2012; Reimann et al. 2015; Polizopoulo et al. 2016) which is thought to support an 
inflammatory component to canine CHF. 
In human CHF, leukocytosis is associated with CHF development (Pfister et al. 2012; Eisen et al. 
2014) and mortality (Rudiger et al.  2005; Arruda-Olson et al. 2009; Riad et al. 2013) and is predictive 
of future hospitalisation (Engström et al. 2009). Monocytosis (Pfister et al. 2012; Shantsila et al. 
2012), relative lymphopenia (Ommen et al. 1998; Acanfora et al. 2001; Rudiger et al. 2006) and 
increased neutrophil to lymphocyte ratio (Duffy et al. 2006; Uthamalingam et al. 2011; Zhang et al. 
2014) are also related to disease severity and mortality. The association between leukocyte 
alterations and prognosis persists in human studies despite heterogeneous causes of CHF and study 
designs (Vaduganathan et al. 2012).  
Alterations in white blood cell subpopulations have previously been described in canine CHF. 
Farabaugh and colleagues (2004) reported that significant leukocytosis with neutrophilia but not 
lymphopenia exists in canine CHF patients relative to controls, although differential leukocyte values 
remained in the reference ranges for most cases. In that study, however, the population size was 
small and further work was recommended to validate these findings. The objective of this study was 
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therefore to support previous evidence of alterations in WBC differential counts in canine CHF 
patients in comparison to controls with a larger population and, as secondary objectives, whether 
underlying disease type (MVD or DCM) or mitral E wave to isovolumic relaxation time correlate with 
WBC differential changes in CHF patients. 
Materials and Methods 
This retrospective study had ethical approval from the local Veterinary Research Ethics Committee 
(VREC84).  
The medical records of all canine CHF patients diagnosed at a companion animal referral hospital 
from 2008 to 2015 were reviewed for suitability. Dogs which had undergone echocardiography and 
coded as CHF and either DCM or MVD in the Echopac (GE, Buckinghamshire, UK) archiving system 
were eligible for inclusion provided they had haematology performed within 24 hours of the 
echocardiogram. Echocardiography and analyses had been generated by cardiology diplomates or 
residents under direct supervision of a diplomate. The underlying diagnosis (MVD or DCM) was 
recorded. An echocardiographic diagnosis of MVD was based on the presence of mitral valve 
thickening, mitral valve regurgitation, left atrial and/or left ventricular dilation on 2-dimensional, M-
mode and colour-flow Doppler echocardiography. An echocardiographic diagnosis of DCM was 
based on the presence of left atrial and left ventricular dilation with systolic dysfunction as per 
published guidelines (Dukes-McEwan et al. 2003) after active exclusion of other cardiac or systemic 
disease which may result in secondary myocardial failure. The echocardiographic measurement, 
mitral E wave velocity to isovolumic relaxation time ratio (E/IVRT) was documented for each case as 
an estimate of left sided filling pressures as it is considered the best echocardiographic indicator for 
predicting the presence of left sided congestive heart failure in dogs with MVD or DCM (Schober et 
al. 2010) however a definitive diagnosis of CHF was based on the presence of pulmonary oedema on 
thoracic radiography. 
White blood cell differentials were generated by a haematology analyser and subsequently checked 
by manual count; only the manual counts were collated for statistical analysis. Exclusions were made 
for congenital heart disease (diagnosed by echocardiography) or concurrent systemic disease, based 
on physical examination and a routine minimum database of haematology and serum biochemistry 
testing. DCM patients with concurrent features of MVD (mitral valve thickening) were excluded from 
the study to allow comparison of these diseases in isolation. In total, seventy-two dogs were 
recruited. A population of dogs without cardiac disease (designated as the control population) was 
selected from the referred hospital population, in which haematology had been carried out as part 
4 
 
of health screening or for investigation of their presenting complaint.  The population was not 
randomly selected however an effort was made to include patients without a strong suspicion for 
cardiac or primary inflammatory disease. Some patients were recruited from a previous cardiac 
screening study and were therefore known to have no cardiac, or other, disease whilst others 
presented for complaints which were not considered primarily inflammatory in nature. All control 
patients had no history or clinical evidence of underlying cardiac disease based on the absence of a 
heart murmur or reported clinical signs associated with congestive heart failure e.g. tachypnoea, 
dyspnoea, exercise intolerance or collapse. A subset of the control patients had undergone 
echocardiography as part of a previous study and were all found to be normal. Dogs were excluded 
from both groups if neoplasia was diagnosed or if there was confirmed or suspected primary 
inflammatory disease.  
For the CHF and control groups, patient signalment, final diagnosis and haematology records were 
retrieved from the hospital computer system (Tristan Veterinary Software, Ltd, 2010). From the 
haematology reports, total white blood cell count and respective differential manual count absolute 
numbers with percentagesof neutrophils, lymphocytes , monocytes , eosinophils  and basophils were 
retrieved.  
Statistical Analysis  
Case-Control Comparison 
Data were initially entered into Excel spreadsheets (Microsoft Corporation, Redmond, WA) and 
statistical analyses were performed using Sigma Plot 12 (SYSTAT Software, 2013). Shapiro-Wilk 
Normality Testing was used to establish the distribution of data sets to enable selection of the 
appropriate parametric or non-parametric methods for statistical comparisons. Basic descriptive 
statistics (mean and standard deviation or median with interquartile range; the latter if non-normal 
distribution) were applied to the haematological results. It was suspected that there could be an 
over-representation of certain breeds between the two groups, especially due to the presence of the 
Great Dane control group and so demographic comparisons were performed. To compare groups 
(e.g. haematological results, age, body-weight), Student’s T-test or Mann-Whitney (if normal or non-
normal data distribution, respectively) were used. To compare categorical data (e.g. sex, breeds) Chi-
squared analysis was used. WBC differentials were compared between the control group subgroups 
using one-way ANOVA. P values of <0.05 were accepted as representing statistical significance. 
As WBC differentials are likely to be correlated, to some extent, within individuals, principal 
components analysis (PCA) was used to investigate these possible associations as well as 
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investigating the effect of CHF as a variable of interest. PCA is a statistical procedure that transforms 
a set of (observed and possibly correlated) variables to a new set of uncorrelated variables called 
principal components (Husson et al. 2010). The transformation is conducted so that the first 
principal component (component 1) contains the largest variance (accounting for as much of the 
variability as possible), with each successive principal component accounting for less variation. In 
this way, it is often possible to explain much of the variation in the original data with a smaller set of 
uncorrelated variables. The PCA approach adopted in this study enabled the relationships between 
the multiple hematological variables to be explored and these patterns, in turn, to be compared with 
other explanatory variables of interest (such as mitral E/IVRT, age) and with the outcomes (case or 
control status) under study. By examining how each variable contributes to the principal 
components, the principal components can be interpreted in terms of variables of interest. 
PCA was performed using the R language for statistical computing (R Core Team, 2016) using the 
FactorMineR package (Husson et al. 2010). Analysis was undertaken in two stages. Firstly, PCA was 
conducted using all data (cases combined with controls) regarding the WBC differentials, and with 
age, sex and case/control status as additional, supplementary variables. Supplementary variables are 
compared with but do not contribute to calculation of the principal components. Weight was not 
considered as a supplementary variable in the case-control group due to the risk of bias given the 
over-representation of Great Danes (known to be a heavy breed) in this group.  Cases and controls 
were then compared with regards to the components identified using PCA and individual WBC 
differentials. These comparisons were made using binary logistic regression (R Core Team, 2016) 
with the dependent variable set as case or control and the independent variable as the principal 
component of WBC differential of interest as well as age.  
Subsequently, analysis of the cases alone was conducted. PCA was used to explore the WBC 
differential data, with age, sex, weight and Mitral E/IVRT measurements included as supplementary 
variables. Linear regression analysis was used to explore the association between Mitral E/IVRT and 
the main principal components, weight and age. The association between Mitral E/IVRT and 
diagnosis (MVD or DCM) was also explored.  Prior to analysis, Mitral E/IVRT was log10 transformed 
to improve normality of the data. In all cases, the relationship between each dependent and 
independent variable was examined using generalised additive models (conducted using the R 
Language for statistical computing with the ‘mgcv’ package). 
Results 
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The CHF group (n=72) consisted of 44 MVD cases and 28 DCM cases. The control group (n= 143) 
included a group of healthy Great Danes (n=35) presented for cardiac screening, dogs presenting to 
the orthopaedic service for chronic lameness investigations (n=24), dogs with a diagnosis of 
idiopathic epilepsy (n=68), and a small number presenting for elective procedures e.g. castration 
(n=3). Further population breakdown is illustrated in Table 1. Comparison of signalment between the 
CHF and control groups (Table 1) found a non-normal distribution of data for weight in both groups. 
The controls were significantly younger (p<0.001) and heavier (p=0.013) than the CHF group. Great 
Danes were over-represented in the controls (p<0.001) and Cavalier King Charles Spaniels in the CHF 
group (p<0.001).  
Basic statistical analysis of the WBC differentials (Table 2) revealed that the CHF group had a 
significantly higher median total WBC count (CHF group 11.96 x109/L, control group 9.0 x109/L, p 
<0.001), neutrophil count (CHF group 8.9 x109/L, control group 6.20 x109/L, p <0.001), monocyte 
count (CHF group 0.5 x109/L, control group 0.37 x109/L, p=0.008) and number of band neutrophils 
(CHF group 0.29 x109/L, control group 0.2 x109/L, p=0.003) than the control group.  Basic statistical 
analysis and comparison of the WBC differentials in the control subgroups found that the Great 
Danes had a significantly lower lymphocyte count (median lymphocyte count 1.2x109/L; p = 0.001, 
idiopathic epilepsy 1.8, chronic lameness 1.9, elective procedures 1.3) than the other sub 
populations however no other significant differences were identified. 
PCA of cases and controls 
The main component of variability (component 1) was associated with neutrophils, band neutrophils 
and monocytes but not with lymphocytes, eosinophils or basophils. In contrast, component 2 was 
associated with lymphocytes, eosinophils and basophils with little contribution from neutrophils, 
bands or monocytes.  Component 3 mainly associated with basophils whereas component 4 
associated with eosinophils and, to some extent, monocytes.  
Components 1 and 2 accounted for 49.22% of the variation in the data (28.98% and 20.24% 
respectively). Components 3 and 4 contributed 17.21% and 14.55% of the data respectively (Table 
3). This was also illustrated as a factor map (Figure 1) which demonstrated the correlations between 
the white cell counts and also the supplementary variable, age. Two variables were significantly 
associated with component 1; case status (correlation 0.42, p<0.010) and age (correlation 0.17, 
p=0.010, see Figure 1). Hence, case animals were more likely to score highly on component 1 (which 
was characterized by relative neutrophilia, increased band neutrophils and relative monocytosis- 
Table 1, also illustrated in Figure 1). Component 2 (lymphocyte, eosinophils and, to a lesser extent, 
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basophils) was significantly negatively associated with case status (correlation -0.15 p = 0.02) and 
age (correlation -0.21, p<0.01). Sex was associated only with component 2 (correlation with males -
0.13, p = 0.049) but not with component 1.  
The relationship between component 1 and 2 is shown in Figure 2. Although there was considerable 
overlap between cases and controls with regards to the components, there was evidence that case 
animals are more likely to score highly on component 1 (neutrophils, band neutrophils and 
monocytes).  
Generalised additive models indicated that the form of the relationship between the outcome (case 
status) and each dependent variable (principal components 1, 2 and age) was approximately linear, 
indicating that this assumption of generalised linear regression analysis was met. The association 
between case-control status and component 1 was further explored using univariable logistic 
regression (Table 4). Component 1 was significantly associated with case-control status (p=0.002) 
with the odds of an individual being a case increasing 2.5 (95% confidence interval: 1.4-4.4) fold for 
each single unit increase in component 1. This increase is a composite of the three WBC types 
incorporated in the principal component (neutrophils, band neutrophils and monocytes) and so it 
cannot be differentiated which cell line predominantly contributes to this. However, univariable 
logistic regression using the WBC differentials as explanatory variables again highlighted the 
increased odds of being a case associated with increases in neutrophils, band neutrophils and 
monocytes (Table 4). The association between case status and lymphocyte, and eosinophil count 
was not significant.  Due to the correlation between some differentials, and because the co-
relationship between the cell types and case status was explored through PCA, as shown above; 
multivariable analysis using all cell types was not performed. The association with component 1 
remained significant (p=0.007) after controlling for age (odds ratio 2.4, 95% confidence interval: 1.4-
4.9). Component 2 was not associated with case status, even after controlling for age. 
Case only analysis 
Among the cases only, similar to the PCA that combined case and control data, component 1 was 
characterised by neutrophils, band neutrophils and monocytes whereas component 2 was 
characterised by lymphocytes and eosinophils (Table 5, Figure 3). Additionally, Mitral E/IVRT most 
strongly correlated with component 1. Component 3 mainly correlated with basophils whereas 
component 4 was weakly correlated with eosinophils and monocytes. Among the cases only, PCA 
identified that components 1 and 2 accounted for 54.7% of the variation in the data (34.39% and 
20.31% respectively). Components 3 and 4 explained an additional 16.92% and 12.63% respectively.  
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Linear regression identified no significant associations between mitral E/IVRT and component 1 or 2 
or with individual WBC differentials, except for neutrophils (p=0.040; Table 6). Diagnosis (MVD or 
DCM) was significantly associated with E/IVRT (p=0.040; Table 6), with MVD having a higher E/IVRT 
than DCM. Controlling for age, sex and weight did not meaningfully affect these associations. 
Diagnosis was also incorporated as a variable into the case-only analysis however no significant 
difference was found between any of the first 4 components (the only components examined). 
There were no significant differences in individual WBC differentials between DCM and MVD (data 
not shown). 
Discussion 
This study identified statistically significant differences between the differential WBC counts of 
canine CHF patients and those of controls. This finding is consistent with previous evidence 
(Farabaugh et al. 2004), however the present study had a larger study population and examined 
both underlying disease process and the relationship to the echocardiographic measurement, mitral 
E/IVRT (a marked of increased left ventricular filling pressures) as secondary objectives.  
In humans, WBC count (specifically granulocyte count) is independently associated with increasing 
CRP levels and risk of heart failure (Pfister et al. 2012). In one study, leukocyte concentrations were 
elevated years before patients were hospitalised due to CHF, suggesting a predictive value 
(Engström et al. 2009). WBC count at hospital admission predicts mortality in human DCM patients 
with severe left ventricular dilation and is therefore an independent predictor of mortality in these 
patients (Riad et al. 2013). Whilst leukocytosis is associated with physiological stress in humans 
(Benschop et al. 1996, Chatterjee et al. 2005), the presence of a relative leukocytosis in human CHF 
is generally inferred to be part of a wider inflammatory response (Arruda-Olson et al. 2009, 
Engström et al. 2009, Riad et. al. 2013). It is postulated that leukocytes release pro-inflammatory 
cytokines e.g. tumour necrosis factor α, interleukin-6 and CRP which then have deleterious effects 
on the myocardium resulting in reduced left ventricular function (Uthamalingam et al. 2011; 
Shantsila et al. 2012). Activated neutrophils may also release proteolytic enzymes which facilitate 
tissue destruction; increased levels of myeloperoxidase have been shown in patients with CHF 
suggesting inflammatory activation (Vasilyev et al. 2005).  
In our study, whilst most CHF patients’ neutrophil, band neutrophil and monocyte counts were 
within accepted reference ranges, a relative neutrophilia, increased band neutrophil count and 
monocytosis (as captured by the first principal component) were associated with canine CHF 
patients in comparison to the control group. The clinical significance of these findings is unclear but 
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it is possible that the presence of a relative neutrophilia could be due to physiological stress in CHF 
patients. There is evidence of physiological stress in canine cardiac patients; Tidholm et al. (2005) 
reported no difference in plasma cortisol between controls and dogs with preclinical and clinical 
DCM, but the urine cortisol-creatinine and urine catecholamine-creatinine ratios were higher in DCM 
patients. We did not distinguish the underlying cause for the relative neutrophilia observed in the 
CHF cases and as other markers of systemic inflammation e.g. CRP were not assayed, we cannot 
conclude that our results are consistent with a systemic inflammatory response as is suggested in 
the human literature.  
Also in humans, a relative lymphopenia is independently associated with survival time in advanced 
heart failure (Ommen et al. 1998) and considered a prognostic indicator in elderly CHF patients 
(Acanfora et al. 2001).  The relative lymphopenia documented in human CHF patients is thought to 
reflect neurohormonal activation (Thomson et al. 1980) and acts as an indirect marker of activation 
of the hypothalamic-pituitary-adrenal axis (Ommen et al.  1998). In contrast to the human literature, 
neither our study nor a smaller previous study (Farabaugh et al. 2004) identified significant 
lymphopenia (which is also an indicator of physiological stress in animals (Stockman et al. 2003)), in 
canine CHF patients in comparison to controls. However our control population did contain an over-
representation of Great Danes with a significantly lower lymphocyte count in comparison to other 
controls which may have confounded our ability to identify significant differences in the lymphocyte 
counts between the CHF group and controls. Additionally, Farabaugh and colleagues (2004) did show 
significant differences between the lymphocyte sub-populations in dogs with CHF compared with 
controls, which was not investigated in our study 
In this study, CHF patients had increased number of band neutrophils in comparison to control 
patients. The presence of band neutrophils is not typically associated with the classical stress 
leukogram and, rather, is considered an indicator of an inflammatory leukogram (Barger 2003, 
Stockham et al. 2003). This result may therefore support the hypothesis of an inflammatory process 
in canine CHF, as described in the veterinary literature (Cunningham et al. 2012; Fonfara et al. 2012; 
Reimann et al. 2015). To the authors’ knowledge, the presence of immature (band) neutrophils has 
not been reported in human CHF. 
Monocytosis in human CHF patients is associated with angiogenesis secondary to myocardial 
damage and elevated left-sided filling pressures (Apostolakis et al. 2010). Increased numbers of 
monocyte-derived endothelial progenitor cells have been demonstrated in heart failure, further 
supporting this (Shantsila et al. 2012). The results of the present study could be further explored in 
veterinary patients to establish if associations exist between monocyte count and cardiac 
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remodeling in canine heart disease. Relative monocytosis in canine CHF has not previously been 
reported in the veterinary literature. 
In this study, WBC differentials were investigated in relation to mitral E/IVRT which is a marker of 
increased left ventricular filling pressures and therefore supportive of the presence of left-sided CHF 
(Schober et al. 2010), justifying further investigations e.g. thoracic radiography. There was a weak 
positive association between neutrophil count independent of other WBC differentials, and mitral 
E/IVRT. Mitral E/IVRT also correlated most strongly with component 1 (neutrophils, band neutrophils 
and monocytes), which is logical given that case status was associated with similar WBC differential 
changes. Despite these findings, analysis of the relationship between principal components 1 and 2 
in all patients showed considerable overlap between our case and control results (Figure 2) and so 
measurement of neutrophil count could not be considered sufficiently discriminatory to justify 
further investigations in patients with suspected left sided congestive heart failure. The weak nature 
of this association may reflect pre-treatment with cardiac medications including diuretics, which may 
have affected results. It would, however be interesting to repeat this study with incorporation of 
other markers of disease severity e.g. left atrial size, left ventricular dimension in diastole and /or 
systole (indexed to body weight (Cornell et al. 2004)), or in DCM cases, variables reflecting systolic 
function such as Simpson’s derived end systolic volume index,ejection fraction and fractional 
shortening especially as there is some evidence of progressive immune activation with  increasing 
severity of cardiac disease in veterinary patients (Cunningham et al. 2012, Ljungvall et al. 2010, 
Polizopoulou et al. 2015). 
No differences were found in WBC differentials between different types of cardiac disease (MVD and 
DCM), although this may reflect reduced statistical power. In humans, significant alterations in WBC 
differentials have been documented in a variety of ischaemic and non-ischaemic cardiac diseases but 
no condition is associated with significantly heightened inflammatory biomarkers in comparison to 
others (Engströem et al. 2009, Pfister et al. 2012). Therefore, the leucogram changes associated with 
CHF may reflect the CHF syndrome itself, rather than the primary cardiac condition leading to CHF.  
Limitations 
The control population recruited in this study was not truly representative of the population from 
which the cases were drawn and were not randomly selected so the potential affect of selection bias 
on results should be taken into consideration. Controls were recruited from a referred population 
and so could not be considered strictly healthy although their presenting complaints were not 
considered to be primarily inflammatory in nature. Unfortunately, blood sampling from completely 
11 
 
healthy pets without clinical justification to do so would be considered unethical and so the inclusion 
of a strictly healthy control population was not achievable. The orthopaedic cases included in the 
controls selection presented for chronic lameness investigations which could arguably have an 
inflammatory component however the patients were clinically well with no clinical suspicion for 
polyarthritis. Idiopathic epilepsy especially is not considered an inflammatory disease based on 
serum or cerebrospinal fluid CRP levels (Narkamura et al. 2007, Bathen-Noethen et al. 2008). 
Additionally, there was no statistical evidence of a significant relative leukocytosis, neutrophilia or 
increased band neutrophil count (features associated with an inflammatory state) in any of the 
control subgroups in comparison to the others. The relative lymphopenia in the Great Dane group 
may reflect breed variation however breed differences in WBC differentials have not been reported 
in the veterinary literature, except in the case of eosinophils (Bourges-Abella et al 340 2011). 
Concurrent testing of acute phase protein levels e.g. CRP to definitively exclude significant 
concurrent inflammatory disease may have improved the validity of the control population.  
The case and control patients were not matched for age, sex, breed or weight and were known to 
include different breed proportions; Great Danes contributed a larger proportion of the control 
population whilst Cavalier King Charles Spaniels were over-represented in the cases. The Great 
Danes were included in the controls as they were known to be clinically healthy with normal 
echocardiographic results at the time of inclusion, which improved the validity of the control 
population. As the CHF population tended to be lighter than the control population, some of our 
findings may be a consequence of differences in breed and weight.  
As the CHF group was a referred population, most were not treatment-naive cases, and may have 
received a variety of cardiac medications prior to echocardiography. We cannot exclude the 
possibility that treatment influenced the results, and serial haematologies would be indicated to 
investigate the effect of treatment.  Additionally, as the CHF group was a referred population and 
cases were restricted to MVD and DCM only (this decision was made as these are the most common 
structural cardiac diseases in dogs (Bonnett et al. 2005)), we cannot state that our findings are 
reflective of all CHF cases managed in primary practice or of dogs with other types of cardiac disease 
(although disease type did not appear to correlate with white blood cell differentials).  
There was overlap between the leukogram results of the case and control groups so, based on our 
population, haematology results in isolation are not sufficiently discriminatory in determining the 
presence of CHF in individual veterinary cardiac patients. Neither can they be considered of 
prognostic value in an individual dog, as an inflammatory leucogram should prompt exclusion of 
other systemic conditions rather than presuming it reflects the concurrent CHF.  
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However, our results do indicate that the potential role of inflammation should be further 
investigated in the syndrome of canine CHF.  
Conclusions 
This study shows that canine CHF patients with MVD or DCM have a statistically significant relative 
neutrophilia and monocytosis and increased band neutrophils in comparison to dogs without CHF, 
independent of underlying cardiac disease. Whilst our results are not of diagnostic or prognostic 
value to the practitioner in the individual case, they may be of interest in elucidating some of the 
complex pathophysiological processes underlying the development of canine CHF. 
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Table 1: Signalments of the CHF and Control groups 
Population 
  CHF (n=72) Control (n=143) 
Breeds Boxer 5 1 
(p<0.001) 
Cavalier 17 4 
 
Cocker Spaniel 6 2 
  Crossbreed 4 13 
  Doberman 8 0 
  Great Dane 4 35 
  
Labrador 
Other Breeds 
5 
23 
11 
78 
Age (Years) 0-4.5 4 67 
(p<0.001) 4.6-8.5 25 49 
  8.6-12.5 36 19 
  12.6+ 6 4 
  Mean 8.89 5.44 
  Standard Deviation 2.78 3.27 
Sex Female (Entire) 4 23 
(p<0.001) Female (Neutered) 22 29 
  Male (Entire) 22 42 
  Male (Neutered) 24 47 
Weight (Kg) 0-9.9 21 5 
(p = 0.013) 10-19.9 16 3 
  20-29.9 10 12 
  30-39.9 10 4 
  40+ 17 29 
  Median 19.5 29.5 
  
25% 
75% 
9.55 
38.5 
14.0 
53.5 
 
Abbreviations: CHF = Congestive Heart Failure, n = number, kg = kilograms 
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Table 2: White blood cell differentials in CHF and control populations 
WBC 
Variable 
CHF Dogs (n=72) Control Dogs (n=143)  
Median 25% 75% Median 25% 75% P Value 
Total WBC (x 
109/L) 11.96 9.68 15.58 9.00 7.41 10.55 
<0.001 
#N (x 109/L) 8.90 6.70 12.00 6.20 5.00 7.60 <0.001 
#L (x 109/L) 1.50 0.96 2.21 1.60 1.10 2.16 0.700 
#M (x 109/L) 0.50 0.26 0.82 0.37 0.21 0.61 0.008 
#Eos (x 109/L) 0.24 0.01 0.48 0.32 0.17 0.49 0.040 
#Bas (x 109/L) 0.01 0.01 0.01 0.01 0.01 0.01 0.008* 
#bands 0.29 0.117 0.825 0.2 0.08 0.37 0.003 
#Platelets(x 
109/L) 287 208 379 277 230 329 
0.432 
%N 75.95 69.10 82.01 69.40 63.20 76.04 
<0.001 
%L 12.98 8.45 18.10 18.0 13.55 24.76 <0.001 
%M 4.02 2.45 6.00 4.96 2.95 6.9 0.110 
%Eos 1.97 0.16 3.97 3.10 1.65 5.60 0.002 
 
 
Abbreviations: WBC = White Blood Cell, #N = neutrophil number, #L = lymphocyte number, #M = 
monocyte number, #Eos = eosinophil number, #Bas = basophil number, #platelets = platelet 
numbers, %N = percentage neutrophils, %L = percentage lymphocytes, %M = percentage monocytes, 
%Eos = percentage eosinophils 
*medians and quartiles identical for #Bas, however the maximum value was 0.9 for controls and 0.1 
for CHF 
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Table 3: Principal components analysis (PCA) showing WBC differential contributions to 
Components 1 & 2 (CHF cases and controls combined). Figures in brackets represent the 
correlation coefficient 
 
 Component 1 
(%) 
Component 2 
(%) 
Component 3 
(%) 
Component 4 
(%) 
Neutrophils 36.98 
(0.8) 
9.60 
(-0.34) 
0.17 
(-0.04) 
6.13 
(0.23) 
Band Neutrophils 33.18 
(0.76) 
2.63 
(0.18) 
1.49 
(-0.12) 
9.80 
(0.98) 
Monocytes 22.43 
(0.62) 
1.74 
(0.15) 
15.46 
(0.4) 
4.22 
(-0.19) 
Lymphocytes 4.09 
(0.27) 
44.71 
(0.74) 
0.39 
(-0.06) 
32.76 
(-0.53) 
Eosinophils 1.49 
(-0.16) 
36.76 
(0.67) 
9.37 
(-0.31) 
36.47 
(0.56) 
Basophils 1.82 
(-0.18) 
4.54 
(0.23) 
73.12 
(0.87) 
10.62 
(0.30) 
Total variance 
explained 
28.98 20.24 17.21 14.55 
Cumulative Total 28.98 49.22 66.43 80.98 
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Table 4: Univariable binary logistic regression investigating the relationships between case/control 
status and the first two principal components and white blood cell counts.  
 Coefficient SE OR 95% CI P value 
Component 1 0.905 0.297 2.5 1.4-4.4 0.002 
Component 2 0.263 0.163 1.3 0.9-1.8 0.100 
Neutrophils 0.373 0.067 1.5 1.3-1.8 <0.001 
Band Neutrophils 1.533 0.428 4.6 2.1-11.2 <0.001 
Lymphocytes -0.051 0.164 1.0 0.7-1.3 0.800 
Monocytes 0.773 0.338 2.2 1.1-4.3 0.020 
Eosinophils -0.389 0.420 0.7 0.3-1.5 0.400 
 
Abbreviations: SE; standard error, OR; Odds Ratio, CI; Confidence Interval 
Footnote: Basophils not included due to negligible numbers
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Table 5: Principal components analysis (PCA) showing WBC differential contributions (correlations) 
to Component 1, 2, 3 and 4 (CHF cases only). Figures in brackets represent the correlation 
coefficient 
 Component 1 
(%) 
Component 2 
(%) 
Component 3 
(%) 
Component 4 
(%) 
Neutrophils 36.54 
(0.87) 
3.03 
(0.19) 
0.79 
(-0.09) 
2.17 
(0.13) 
Band Neutrophils 23.98 
(0.7) 
7.25 
(0.30) 
17.98 
(-0.43) 
16.41 
(0.35) 
Monocytes 15.91 
(0.57) 
10.68 
(0.36) 
3.19 
(0.18) 
62.44 
(-0.69) 
Lymphocytes 8.82 
(-0.43) 
41.72 
(0.71) 
0.00 
(0.01) 
0.38 
(-0.05) 
Eosinophils 11.32 
(-0.48) 
35.51 
(0.66) 
0.72 
(-0.09) 
3.46 
(0.16) 
Basophils 3.44 
(0.27) 
1.81 
(0.15) 
77.32 
(0.89) 
15.14 
(0.34) 
Total variance explained 
34.39 20.31 16.92 12.63 
Cumulative total variance 
explained 34.39 54.71 71.63 84.25 
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Table 6: Univariable linear regression results investigating, among the CHF cases, the association 
between E/IVRT (log10) and principal components 1 and 2, white blood cell counts and diagnosis. 
 Coefficient SE P 
value 
Component 1 0.022 0.017 0.200 
Component 2 0.022 0.020 0.300 
Neutrophils 0.020 0.010 0.040 
Band 
Neutrophils 
0.122 0.088 0.200 
Lymphocytes -0.046 0.065 0.500 
Monocytes 0.033 0.123 0.800 
Eosinophils 0.086 0.146 0.600 
Basophils -1.939 3.708 0.060 
Diagnosis 
DCM 
MVD 
 
Reference 
0.224 
 
 
0.108 
 
 
0.040 
 
Abbreviations: SE standard error , CI Confidence Interval, DCM Dilated Cardiomyopathy, MVD Mitral 
Valve Disease 
Figure 1: Variable factor map demonstrating alignment of each WBC Differential (in black) in 
relation to Components 1 (x-axis) & 2 (y-axis) (from PCA using case and control data). The 
association with each component with the supplementary continuous variable age is shown in 
blue. 
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Abbreviations: eos = eosinophils, baso = basophils, mono = monocytes, neut = neutrophils, lymph = 
lymphocytes 
 
 
 
 
 
 
 
 
 
 
Figure 2: Individual factor map demonstrating individual response to components 1 (Dim 1) and 2 
(Dim 2) (black dots = control patients, red dots = CHF patients) 
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Figure 3: Variable factor map demonstrating alignment of each white cell line in relation to 
Components 1 & 2 obtained from the PCA using CHF cases. The association with each component 
with the supplementary continuous variables age, weight and E/IVRT are shown in blue. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: eos = eosinophils, bas = basophils, mono = monocytes, neut = neutrophils, lymph = 
lymphocytes, E/IVRT = mitral E/IVRT 
 
 
 
 
